Authors

HDA 2025 Traceability Seminar: Closing Gaps in Pharma’s Supply Chain

Ullrich Mayeski, community engagement director of health with GS1 US, emphasizes the critical need to address interoperability challenges at the dispenser level, ranging from small independent pharmacies to large hospital systems.

Building Intelligent Pharma Supply Chain Management with Real-World Data

Approaches powered by RWD can clear the way for a greater focus on patient-centered care.

Serialization 2.0: Why It’s Time to Upgrade, and What’s at Stake

This serialization system represents a business imperative that yields significant competitive advantages.

Rethinking Medicare Price Negotiations: Innovation, Insurance Reform, and Patient Access

In the final part of his Pharma Commerce video interview, John Stanford, Incubate’s executive director, argues that while Medicare price controls may reduce federal spending, they have yet to meaningfully improve patient access—contending that true reform must address insurance design, out-of-pocket costs, and the long-term impact on life sciences innovation and investment.

Navigating the Landscape of Global AI Governance

The importance of embracing universal values and business models that prioritize humanity.

The Ways Pharma Leaders are Rewiring their Organizations for Launch Success

HTI-4 Standards Target Lack of Transparency in Medication Access

In the final part of his Pharma Commerce video interview, Colin Banas, MD, DrFirst’s chief medical officer, explains how amid soaring patient and provider frustration, new HTI-4 standards are rapidly forcing change across the insurance and technology sectors to solve the current "transparency problem," making the status of a life-saving prescription as clear and actionable as tracking a takeout order.

Community Pharmacies in Crisis: Navigating the Challenges and Closures

With today's pharmacy landscape shaken by unprecedented and wider disruption to healthcare support and delivery, community and independent entities strive to remain an integral cog in the mix.

The Great Repricing: Seven Assumptions That No Longer Hold

Pharma pricing shifts beyond PBM rebates as Medicare and cash channels reshape launches, WAC cuts and access strategies.

How Rare Disease Therapies Evolved Into a Strategic Growth Engine for Biopharma

Rare disease drugs now drive innovation, investment, and portfolio strategy as policy incentives, scientific advances, and market success reshape biopharmaceutical growth.

ClaimGuardRx Shapes How Programs are Designed, Priced, and Optimized From the Start

Matt Turner shares how ClaimGuardRx is redefining patient affordability by turning claims data into a proactive defense against maximizers and accumulators.

Navigating Access and Reimbursement Through Uncertainty

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

Working with the Middle

How pharma can productively coexist with PBMs—and still lower drug costs faster.

Doceree CEO: AI Should Extend the Field Force, Not Replace It

In this Q&A, Doceree CEO Harshit Jain, MD, explains why AI should inform prescribing decisions, not drive them, and how sales reps own relationships while AI extends reach.

The Prominence of Pharmacy Deserts

How chain and local closures are impacting healthcare access.

Quality and Compliance in the Pharmaceutical Industry: Navigating a Transformed Landscape

Rising recalls, tighter FDA enforcement, global supply chain dependencies, and rapid technology shifts are reshaping pharmaceutical quality and compliance—forcing manufacturers to rethink oversight, resilience, and continuous improvement across operations.

Q&A: Where Direct-to-Patient Pharma Stands Today

Gifthealth CEO Chip Parkinson on the factors accelerating direct-to-patient model adoption, and what's next for the channel.

Your Guide to Outsourcing Critical Sample Management

Discover how to evaluate the true costs and considerations of internal vs. outsourced sample storage.

Pharmaceutical Cold-Chain Logistics: Protecting Integrity from End to End (Aug 2026)

In this article, we explore how cold-chain logistics are evolving to support the unique demands of the pharmaceutical industry. From precision temperature control and proactive compliance management to real-time visibility and mission-critical support systems, discover the strategies that help ensure safe, reliable delivery of temperature-sensitive medicines. Featuring insights into emerging expectations for traceability, rapid response protocols, and customized logistics solutions, this piece highlights how best-in-class cold-chain practices build resilience and protect product integrity.

Addressing Polypharmacy Challenges in Europe with Real World Evidence

A multi-national study reveals over half of older adults in several European countries are prescribed five or more medications—spotlighting the urgent need for better data-driven prescribing strategies.

Why the Next Wave of Drug Launches Will Be Won on Market Access

Thani Jambulingam, Ph.D., says MFN pricing, Section 232 tariffs and PBM reform will converge to shape how pharma launches and commercializes new drugs.

How DSCSA Compliance Is Unlocking Recall Efficiency

In the final part of his Pharma Commerce video interview, Dan Walles, VP & GM, traceability and compliance solutions, TraceLink, notes that while DSCSA was designed for compliance, its first major business value is enabling targeted recalls.

Q&A: Will National Licensure Simplify Distributor Compliance?

HDA's Kala Shankle says a federal licensure baseline could bring real efficiency gains for wholesale distributors and 3PLs, but only if state requirements align and every stakeholder moves on the same timeline.

The performance gaps most fleet programs can’t see

How pharmaceutical and life sciences fleets can uncover hidden operational costs by connecting maintenance, telematics, fuel, routing, and lifecycle decisions

Omnichannel, Evolved: Redefining the Model for Modern Pharma Marketing

Pharma must align data, personalization, and cross-functional orchestration to deliver human-centered experiences that connect with patients, HCPs, and caregivers alike.

Building Agility and Adaptability Into Pharma Operations

Why driving results from such strategies—amid industry disruption—will be critical to success.

The Competitive Edge in Pharma Logistics: Sustainability, Safety, and Precision Delivery

DSCSA Compliance Guide: What to do now that enforcement as begun

DSCSA compliance did not end with implementation. Learn what your organization should monitor, test and strengthen now that FDA enforcement is underway.